Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient - PubMed (original) (raw)
Comparative Study
. 1991 Jan-Feb;19(1):36-43.
Affiliations
- PMID: 1673419
Comparative Study
Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient
S P Robinson et al. Drug Metab Dispos. 1991 Jan-Feb.
Abstract
The metabolism of tamoxifen was examined in the rat, mouse, and human breast cancer patient. Large oral doses of tamoxifen (200 mg/kg) in the immature ovariectomized rat and mature mouse produced circulating levels of the parent compound, N-desmethyltamoxifen, and 4-hydroxytamoxifen quantifiable by HPLC separation, UV activation, and fluorescence detection. N-Desmethyltamoxifen and 4-hydroxytamoxifen serum levels in the mature ovariectomized mouse paralleled tamoxifen levels throughout a 96-hr time course after a single dose of tamoxifen. On the other hand, N-desmethyltamoxifen was the predominant serum metabolite after an equivalent dose of tamoxifen to the immature rat, but there was little 4-hydroxytamoxifen. Peak levels of tamoxifen occurred 3-6 hr after oral administration of tamoxifen in both species, whereas peak levels of N-desmethyltamoxifen in the immature rat did not occur until 24-48 hr. AUCs for tamoxifen and N-desmethyltamoxifen were approximately 4 times greater in the rat (57.5 and 111 micrograms.hr/ml, respectively) than the mouse (15.9 and 26.3 micrograms.hr/ml, respectively) after equivalent doses of tamoxifen (200 mg/kg). AUC of 4-hydroxytamoxifen for the rat (8.9 micrograms.hr/ml), however, was similar to that for the mouse (13.9 micrograms.hr/ml). The rate of elimination from serum was similar for tamoxifen, N-desmethyltamoxifen, and 4-hydroxytamoxifen in both the rat (t1/2 = 10.3, 12.1, and 17.2 hr, respectively) and the mouse (t1/2 = 11.9, 9.6, and 6 hr, respectively). Administration of large oral doses of tamoxifen (200 mg/kg) every 24 hr to mature ovariectomized mice or immature ovariectomized rats resulted in accumulation for the first 4 days.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts.
Robinson SP, Langan-Fahey SM, Jordan VC. Robinson SP, et al. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1769-76. doi: 10.1016/0277-5379(89)90347-7. Eur J Cancer Clin Oncol. 1989. PMID: 2632258 - Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.
Lien EA, Solheim E, Ueland PM. Lien EA, et al. Cancer Res. 1991 Sep 15;51(18):4837-44. Cancer Res. 1991. PMID: 1893376 - Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
Poon GK, Chui YC, McCague R, Lłnning PE, Feng R, Rowlands MG, Jarman M. Poon GK, et al. Drug Metab Dispos. 1993 Nov-Dec;21(6):1119-24. Drug Metab Dispos. 1993. PMID: 7905393
Cited by
- Macrophages upregulate mural cell-like markers and support healing of ischemic injury by adopting functions important for vascular support.
Amoedo-Leite C, Parv K, Testini C, Herrera-Hidalgo C, Xu F, Giraud A, Malaquias M, Fasterius E, Holl D, Seignez C, Göritz C, Christoffersson G, Phillipson M. Amoedo-Leite C, et al. Nat Cardiovasc Res. 2024 Jun;3(6):685-700. doi: 10.1038/s44161-024-00478-0. Epub 2024 Jun 6. Nat Cardiovasc Res. 2024. PMID: 39196227 Free PMC article. - In vitro small molecule screening to inform novel candidates for use in fluconazole combination therapy in vivo against Coccidioides.
Mead HL, Valentine M, Yin H, Thompson Iii GR, Keim P, Engelthaler DM, Barker BM. Mead HL, et al. Microbiol Spectr. 2024 Oct 3;12(10):e0100824. doi: 10.1128/spectrum.01008-24. Epub 2024 Aug 20. Microbiol Spectr. 2024. PMID: 39162534 Free PMC article. - Refined tamoxifen administration in mice by encouraging voluntary consumption of palatable formulations.
Vanhecke D, Bugada V, Steiner R, Polić B, Buch T. Vanhecke D, et al. Lab Anim (NY). 2024 Aug;53(8):205-214. doi: 10.1038/s41684-024-01409-z. Epub 2024 Jul 30. Lab Anim (NY). 2024. PMID: 39080504 Free PMC article. - Long-Term Oral Tamoxifen Administration Decreases Brain-Derived Neurotrophic Factor in the Hippocampus of Female Long-Evans Rats.
Been LE, Halliday AR, Blossom SM, Bien EM, Bernhard AG, Roth GE, Domenech Rosario KI, Pollock KB, Abramenko PE, Behbehani LM, Pascal GJ, Kelly ME. Been LE, et al. Cancers (Basel). 2024 Mar 31;16(7):1373. doi: 10.3390/cancers16071373. Cancers (Basel). 2024. PMID: 38611051 Free PMC article. - Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ.
Ludwik KA, Greathouse FR, Han S, Stauffer K, Brenin DR, Stricker TP, Lannigan DA. Ludwik KA, et al. Cell Oncol (Dordr). 2024 Apr;47(2):481-496. doi: 10.1007/s13402-023-00877-8. Epub 2023 Sep 30. Cell Oncol (Dordr). 2024. PMID: 37776423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical